(Press-News.org) Contact information: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press
Fungus-fighting drug may make mild flu meaner
Mice given a drug commonly used in patients to fight systemic fungal infections more often succumb to what would otherwise be a mild case of the flu. The evidence reported in the Cell Press journal Cell Reports on November 21st shows that the drug called Amphotericin B, which has an estimated $330 million in sales around the world each year, can render a protein important for antiviral defense ineffective in both cells and mice.
The findings suggest that patients receiving the antifungal therapy may be functionally immunocompromised and more vulnerable to influenza and other viral infections, the researchers said.
"Many critically ill cancer and bone marrow transplant patients are treated with Amphotericin B-based therapies each year," said Abraham Brass of the University of Massachusetts Medical School (UMMS). "Given these results in cells and mice, it may be worthwhile to consider that patients receiving, or who may receive, Amphotericin B-based therapies be appropriately vaccinated against influenza virus. Also, clinical consideration may be given to close monitoring of patients receiving Amphotericin B-based therapies for any symptoms suggestive of flu so that they might be considered for the early administration of an antiflu therapy."
The researchers showed that Amphotericin-B prevents the antiviral protein in cells known as IFITM3 from fending off influenza A virus.
"When we treated lung cancer cells with the antifungal drug, we saw the antiviral protection from IFITM3 pretty much disappear," explained Christopher Chin, co-first author, also from UMMS.
When researchers in Paul Kellam's group at the Wellcome Trust Sanger Institute exposed mice treated with Amphotericin-B to influenza A virus, the animals became very ill and lost more than 25 percent of their body weight. Those symptoms looked very similar to those in animals completely lacking the protective IFITM3 protein. Mice that had not been treated with Amphotericin-B experienced only a moderate illness and recovered fully, as expected. In effect, treatment with Amphotericin-B converted a mild illness for the mice into a life-threatening one.
"Sometimes a very useful drug can have unforeseen effects, and the more we can learn about such things, the better care we can provide," Brass said.
The new study should prompt further clinical research. For instance, he added, studies could be designed to monitor both the number and the severity of flu infections in patients receiving Amphotericin B-based therapies.
###
Cell Reports, Lin et al.: "Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-mediated Restriction."
Fungus-fighting drug may make mild flu meaner
2013-11-21
ELSE PRESS RELEASES FROM THIS DATE:
Newborn babies have built-in body awareness ability
2013-11-21
Newborn babies have built-in body awareness ability
Scientists identify gene that regulates body weight in humans and mice
2013-11-21
Scientists identify gene that regulates body weight in humans and mice
Research has pointed to the importance of genetic factors in human obesity and has shown that heritability plays a role in 40% to 90% of cases. Now investigators reporting online November 21 in The American ...
Scientists find the invisibility cloak that shields HIV-1 from the immune system
2013-11-21
Scientists find the invisibility cloak that shields HIV-1 from the immune system
Of the two major types of HIV, only one, HIV-1, typically causes AIDS in infected people who don't receive treatment. A study published by Cell Press November 21st in the journal Immunity reveals ...
Stanford scientists think mysterious virus could be a signal of a weak immune system
2013-11-21
Stanford scientists think mysterious virus could be a signal of a weak immune system
Genomic analysis of transplant patients finds an opportunistic microorganism whose elevated presence could be used an indicator in treatment
STANFORD, Calif. — More than ...
Different cellular mechanisms behind regenerated body parts
2013-11-21
Different cellular mechanisms behind regenerated body parts
Scientists at Karolinska Institutet in Sweden have discovered that two separate species of salamander differ in the way their muscles grow back in lost body parts. Their findings on the species-specific ...
HIV and parenting needs to be discussed, new study finds
2013-11-21
HIV and parenting needs to be discussed, new study finds
A team from Royal Holloway University and St. Mary's Hospital, London, interviewed young people aged 18-23 who had transmitted HIV from their mothers – known as 'perinatally acquired HIV' (PAH). Previously ...
Genetic defect keeps verbal cues from hitting the mark
2013-11-21
Genetic defect keeps verbal cues from hitting the mark
Gene found in human speech problems affects singing, not learning in songbirds
DURHAM, N.C. -- A genetic defect that profoundly affects speech in humans also disrupts the ability of songbirds to sing effective courtship ...
Study pinpoints cell type and brain region affected by gene mutations in autism
2013-11-21
Study pinpoints cell type and brain region affected by gene mutations in autism
UCSF-led study zeroes in on when and where disrupted genes exert effects
A team led by UC San Francisco scientists has identified the disruption of a single type of ...
Research shows that anti-fungal medicine may increase vulnerability to influenza and other viruses
2013-11-21
Research shows that anti-fungal medicine may increase vulnerability to influenza and other viruses
First line anti-viral protein rendered ineffective by Amphotericin B
WORCESTER, MA – Scientists at the University of Massachusetts Medical ...
UCLA first to map autism-risk genes by function
2013-11-21
UCLA first to map autism-risk genes by function
Scientists unravel how mutations disrupt fetal brain's development
Pity the poor autism researcher. Recent studies have linked hundreds of gene mutations scattered throughout ...